Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology
Disease Category: Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
Trial Information
Maintenance of Benefit after 8 and 52-week Treatment for Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)
This is a medication trial in which all who qualify will receive
a non-stimulant medication for ADHD and will be assessed for
improvement in family functioning, academic performance, grade
point average, and health outcomes.
Compensation Provided
Patient Inclusion/Exclusion Criteria:
Males and Females ages 13-16
Weight between 88 and 154 lbs.
Must meet criteria for ADHD
In good general health
Pregnant or nursing females
Adolescents who are doing well with their current ADHD
treatment
Robyn C Palmero, M.A.
Mount Sinai Medical Center
One Gustave L. Levy Place
New York, NY 10029
Phone: 212-659-8833
Fax: 212-849-2690
EMail: robyn.palmero@mssm.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
